CEACAM4 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-10587
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the N terminal region of human CEACAM4 (NP_001808). Peptide sequence FTIEALPSSAAEGKDVLLLACNISETIQAYYWHKGKTAEGSPLIAGYITD
Clonality
Polyclonal
Host
Rabbit
Theoretical MW
26 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Scientific Data Images for CEACAM4 Antibody
Western Blot: CEACAM4 Antibody [NBP3-10587]
Western Blot: CEACAM4 Antibody [NBP3-10587] - Western blot analysis using NBP3-10587 on Human Lung as a positive control. Antibody Titration: 0.2-1 ug/mlApplications for CEACAM4 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CEACAM-4
Long Name
Carcinoembryonic Antigen-related Cell Adhesion Molecule 4
Alternate Names
CEACAM4, CGM7
Gene Symbol
CEACAM4
Additional CEACAM-4 Products
Product Specific Notices for CEACAM4 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...